Article
Mutations in PTPN11 could lead to a congenital myasthenic syndrome phenotype: a Noonan syndrome case series.
Journal of neurology - 1 Mar 2024
Pugliese Alessia, Della Marina Adela, de Paula Estephan Eduardo, Zanoteli Edmar, Roos Andreas, Schara-Schmidt Ulrike, Hentschel Andreas, Azuma Yoshiteru, Töpf Ana, Thompson Rachel, Polavarapu Kiran, Lochmüller Hanns
Abstract excerpt
The RASopathies are a group of genetic rare diseases caused by mutations affecting genes involved in the RAS/MAPK (RAS-mitogen activated protein kinase) pathway. Among them, PTPN11 pathogenic variants are responsible for approximately 50% of Noonan syndrome (NS) cases and, albeit to a lesser extent, of Leopard syndrome (LPRD1), which present a few overlapping clinical features, such as facial dysmorphism,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
